Your search returned 7 results.

Results
	1.	The feasibility of physiologically based pharmacokinetic modeling in forensic medicine illustrated by the example of morphine. [electronic resource] by Schaefer, Nadine Moj, Daniel Lehr, Thorsten Schmidt, Peter H Ramsthaler, Frank Producer: 20180816 In: International journal of legal medicine vol. 132 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin. [electronic resource] by Hanke, Nina Frechen, Sebastian Moj, Daniel Britz, Hannah Eissing, Thomas Wendl, Thomas Lehr, Thorsten Producer: 20191028 In: CPT: pharmacometrics & systems pharmacology vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Model of Dabigatran Etexilate, Dabigatran and Dabigatran Glucuronide in Healthy Adults and Renally Impaired Patients. [electronic resource] by Moj, Daniel Maas, Hugo Schaeftlein, André Hanke, Nina Gómez-Mantilla, José David Lehr, Thorsten Producer: 20200910 In: Clinical pharmacokinetics vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification. [electronic resource] by Moj, Daniel Britz, Hannah Burhenne, Jürgen Stewart, Clinton F Egerer, Gerlinde Haefeli, Walter E Lehr, Thorsten Producer: 20171129 In: Cancer chemotherapy and pharmacology vol. 80 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens. [electronic resource] by Moj, Daniel Hanke, Nina Britz, Hannah Frechen, Sebastian Kanacher, Tobias Wendl, Thomas Haefeli, Walter Emil Lehr, Thorsten Producer: 20171128 In: The AAPS journal vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin-integration of in vitro results, Phase I and Phase II data and model application for drug-drug interaction potential analysis. [electronic resource] by Hanke, Nina Teifel, Michael Moj, Daniel Wojtyniak, Jan-Georg Britz, Hannah Aicher, Babette Sindermann, Herbert Ammer, Nicola Lehr, Thorsten Producer: 20190122 In: Cancer chemotherapy and pharmacology vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	A Physiologically Based Pharmacokinetic Model of Voriconazole Integrating Time-Dependent Inhibition of CYP3A4, Genetic Polymorphisms of CYP2C19 and Predictions of Drug-Drug Interactions. [electronic resource] by Li, Xia Frechen, Sebastian Moj, Daniel Lehr, Thorsten Taubert, Max Hsin, Chih-Hsuan Mikus, Gerd Neuvonen, Pertti J Olkkola, Klaus T Saari, Teijo I Fuhr, Uwe Producer: 20210920 In: Clinical pharmacokinetics vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)